• Explore /
  • Poster
  • / A phase II study of atezolizumab and cobimetinib in PD-1/PD-L1 inhibitor resistant or refractory non-small cell lung cancer: <span style="font-size: xx-small;" size="1"></span>ETCTN<span style="font-size: xx-small;" size="1"></span> #10166.

A phase II study of atezolizumab and cobimetinib in PD-1/PD-L1 inhibitor resistant or refractory non-small cell lung cancer: ETCTN #10166.

Abstract Poster

Authors

Stephen V. Liu

Stephen V. Liu

Georgetown University, Washington, DC

Stephen V. Liu , Richard Delmar Hall , Andreas Nicholas Saltos , Gregory Alan Otterson , Ming Tony Tan , Sacha Gnjatic , Ryan D. Gentzler , Tawee Tanvetyanon , Helen X. Chen , Elad Sharon

Sign-In to See More Abstracts, Journal Articles, Posters, Videos and Slides and to Bookmark Your Favorite Content.

Disclaimer

This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org

Poster Details

Meeting

2020 ASCO Virtual Scientific Program

Session Type

Poster Session

Session Title

Lung Cancer—Non-Small Cell Metastatic

Track

Lung Cancer

Sub Track

Metastatic Non–Small Cell Lung Cancer

Clinical Trial Registration Number

NCT03600701

Citation

J Clin Oncol 38: 2020 (suppl; abstr TPS9638)

DOI

10.1200/JCO.2020.38.15_suppl.TPS9638

Abstract #

TPS9638

Poster Bd #

404

Abstract Disclosures

Similar Posters

First Author: Thatcher Ross Heumann

First Author: Nashat Gabrail

First Author: Shipra Gandhi

First Author: Sarah B. Goldberg